Paper65605
High remission-induction rate in acute myeloid leukaemia.
Gale RP and 1 other. Lancet, 1977. Cited by 162 papers, by iCite.
Cite this record
ConductScience Library. High remission-induction rate in acute myeloid leukaemia. Papers, record 65605. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/65605
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytarabine | Major topic |
| Daunorubicin | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Thioguanine | Major topic |
| Administration, Oral | |
| Adult | |
| Age Factors | |
| Aged | |
| Drug Administration Schedule | |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Injections, Intravenous | |
| Male | |
| Middle Aged | |
| Remission, Spontaneous | |
| Time Factors |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27517413 | Acute myeloid leukaemia-A review of sixty-seven cases. | Ir J Med Sci | 1979 | https://conductscience.org/library/papers/27517413 | PubMed |
| 26965440 | Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia. | Leukemia | 2016 | https://conductscience.org/library/papers/26965440 | PubMed |
| 25517921 | Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia. | Braz J Med Biol Res | 2015 | https://conductscience.org/library/papers/25517921 | PubMed |
| 20425452 | The role of timed sequential chemotherapy in adult acute myelogenous leukemia. | Curr Hematol Malig Rep | 2008 | https://conductscience.org/library/papers/20425452 | PubMed |
| 8149141 | Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden. | Support Care Cancer | 1993 | https://conductscience.org/library/papers/8149141 | PubMed |
| 8061102 | A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia. | Ann Hematol | 1994 | https://conductscience.org/library/papers/8061102 | PubMed |
| 7347042 | Remission-induction regimens in acute nonlymphocytic leukemia. | West J Med | 1980 | https://conductscience.org/library/papers/7347042 | PubMed |
| 7260406 | Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL). Treatment report on 60 patients. | Blut | 1981 | https://conductscience.org/library/papers/7260406 | PubMed |
| 7139848 | A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7139848 | PubMed |
| 7015003 | [Bone marrow transplantation for relapsed, acute leukaemia (author's transl)]. | Klin Wochenschr | 1981 | https://conductscience.org/library/papers/7015003 | PubMed |
| 7003128 | Chemotherapy of the myeloid leukaemias. | J R Coll Physicians Lond | 1980 | https://conductscience.org/library/papers/7003128 | PubMed |
| 7000284 | Advances in the management of adult acute myelogenous leukaemia. | Br Med J | 1980 | https://conductscience.org/library/papers/7000284 | PubMed |
| 6954016 | Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)]. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6954016 | PubMed |
| 6931626 | [Long-term survival of adults with acute leukemia [author's transl)]. | Blut | 1980 | https://conductscience.org/library/papers/6931626 | PubMed |
| 6931109 | Acute myelogenous leukaemia with bilateral mammary gland involvement. | J Clin Pathol | 1980 | https://conductscience.org/library/papers/6931109 | PubMed |
| 6930301 | Null results in clinical trials: the need for a decision-theory approach. | Br J Cancer | 1980 | https://conductscience.org/library/papers/6930301 | PubMed |
| 6928791 | The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia. | Blut | 1980 | https://conductscience.org/library/papers/6928791 | PubMed |
| 6887757 | Antimicrobial prophylaxis in acute leukaemia: prospective randomized study comparing two methods of selective decontamination. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6887757 | PubMed |
| 6803909 | Short-term treatment for acute myelogenous leukaemia. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6803909 | PubMed |
| 6781618 | Long survival in acute myelogenous leukaemia: an international collaborative study. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6781618 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/65605
GET https://conductscience.org/api/papers/v1/65605/cited_by?page=2